Role of interleukin-10 in idiopathic pulmonary fibrosis

Tsoutsou P.G., Gourgoulianis K.I.

Source: Eur Respir J 2004; 23: 179-180
Journal Issue: January
Disease area: Interstitial lung diseases

PDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Tsoutsou P.G., Gourgoulianis K.I.. Role of interleukin-10 in idiopathic pulmonary fibrosis. Eur Respir J 2004; 23: 179-180

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of MUC4 in idiopathic pulmonary fibrosis
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018

Role of MUC4 in idiopathic pulmonary fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019

Role of the inflammasome in idiopathic pulmonary fibrosis
Source: International Congress 2017 – New insights into pathogenesis of lung disease 
Year: 2017

Role of midkine in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013

Role of TGF-beta and IFN-gamma in interstitial pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 719s
Year: 2004

Inhalation therapy of interferon-gamma in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 266s
Year: 2005

Pathogenesis of idiopathic pulmonary fibrosis: role of neutrophil inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 102s
Year: 2006

PP217 – Modeling idiopathic pulmonary fibrosis on a lung-on-chip
Source: ERS Lung Science Conference 2021
Year: 2021

Role of IL-11 in vascular function of pulmonary fibrosis patients
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019

Exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2016 – Russia Session
Year: 2016

Dysregulation of the TGF-beta system in idiopathic pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 10s
Year: 2004

Angiogenesis in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020


Differential metabolism of hyaluronic acid in patients with idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015

Anti-fibrotic role of inhaled interferon-γ in idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


Idiopathic pulmonary fibrosis
Source: Eur Respir Monogr 2015; 68: 50-63
Year: 2015


Idiopathic pulmonary fibrosis
Source: International Congress 2018 – State of the art session: Interstitial lung diseases
Year: 2018


Idiopathic pulmonary fibrosis
Source: School Course 2014 - Interstitial lung diseases
Year: 2014

Idiopathic pulmonary fibrosis
Source: Eur Respir Monogr 2013; 62: 37-53
Year: 2013


Pirfenidone in idiopathic pulmonary fibrosis
Source: Eur Respir J 2010; 36: 695-696
Year: 2010



Pirfenidone in idiopathic pulmonary fibrosis
Source: Eur Respir J 2010; 35: 821-829
Year: 2010